Explore the research behind lung cancer vaccines, including mRNA and personalised approaches. Understand the potential for prevention and treatment, plus the latest clinical trial updates.
Prof Ben Solomon and Nick Pavlakis, have secured a landmark $14,707,962 in funding for the ASPiRATION-2 Liquid clinical trial.
Anthony Barrett shares his journey at the 2024 Annual Sientific Meeting as part of the opening address.
Research has given Natalie 10-years of life and she know that inspiring clinical research is the key to saving lives.
TOGA's 2024 Annual Report is here detailing a year of significant progress and growth in membership, engagement, and research funding.
Clinical trials are the bedrock of this progress, driving the development of new and more effective treatments that can significantly improve the lives of individuals
An observational cohort study to assess the clinical impact of comprehensive genomic profiling in metastatic lung cancer patients
An observational cohort study to assess the clinical impact of comprehensive genomic profiling in metastatic lung cancer patients
TOGA is excited to be part of the European Thoracic Oncology Platform (ETOP) ADOPT-Lung clinical trial, with recruitment expected to open towards the end of
DYNAMALK is a significant clinical trial investigating the potential of comprehensive genomic profiling to revolutionize the treatment of ALK+ Non-Small Cell Lung Cancer (NSCLC)
SHERLOCK is a clinical research study, being led by TOGA and coordinated by the NHMRC CTC, looking at the effectiveness of a new treatment combination
The Thoracic Oncology Group of Australasia (TOGA) is thrilled to announce the recipients of the 2025 Inspirational Research Grants.
The Inspirational Research Grant has been created from philanthropic donations to increase research into prevention, treatment, or improved lives of those living with thoracic cancers.
Every year in November, we come together for Lung Cancer Awareness Month. It's a time to raise awareness about thoracic cancers, honour those affected, and
TOGA is excited to announce that it has been awarded a grant as part of the 2024-2027 Support for Cancer Clinical Trials Program.
This meeting provided a full slate with 9 concepts submitted. The concepts spanned the interest areas of every working group and we thank those who
Finding the right clinical trial can be a crucial step in your cancer treatment journey. The Australian Cancer Trials website is a valuable resource for
The Inspirational Research Grant has been created from philanthropic donations to increase research into prevention, treatment, or improved lives of those living with thoracic cancers.
As we expand our cancer healthcare, it is essential to explore innovative ways to optimise the role of SCLNs and ensure that patients with lung
The Inspirational Research Grant has been created from philanthropic donations to increase research into prevention, treatment, or improved lives of those living with thoracic cancers.
We are pleased to announce some exciting changes to the TOGA Board of Directors.
ALK Positive Australia Inc. and the Thoracic Oncology Group of Australia (TOGA) are honoured to announce a new grant partnership dedicated to advancing ALK+ NSCLC
We are pleased to announce some exciting changes to the TOGA Board of Directors.
We’ve all seen the exciting ‘practice-changing’ results presented at conferences like ESMO 2023. But how do these new cancer treatments become available for everyday use
The Inspirational Research Grant has been created from philanthropic donations to increase research into prevention, treatment, or improved lives of those living with thoracic cancers.
We’ve all seen the exciting ‘practice-changing’ results presented at conferences like ESMO 2023. But how do these new cancer treatments become available for everyday use
August 11, 2024
Join the team to run or walk Sydney’s iconic 14km course from the CBD to Bondi Beach on Sunday 11 August 2024.
Angeline Low wasn't your typical candidate for lung cancer. A busy corporate leader with a Ph.D., and an active member of various boards, Angeline embodied
Lung cancer remains a leading cause of death, and nurses specialising in this area play a critical role in patient care. However, securing funding for
This meeting provided a full slate with 9 concepts submitted. The concepts spanned the interest areas of every working group and we thank those who
Last week brought fantastic news for the fight against lung cancer. The Australian Government announced a record-breaking $1.89 billion investment in health and medical research,
Have you been diagnosed with lung cancer and are overwhelmed by treatment options?
Imagine a world where medical research doesn’t have to start from scratch. Imagine a treasure trove of valuable data readily available to answer new questions
OCEANiC is a phase II multi-centre clinical trial targeting patients with resected stage II to IIIA EGFR mutant NSCLC. The trial provides access to Osimertinib
Facing a diagnosis can be a daunting journey, rife with uncertainty and difficult decisions. Among these decisions is the choice of whether to participate in
Three compelling reasons why becoming a participant in cancer clinical trials is not only a noble endeavor but also a decision that can hold profound
August 13, 2023
Congratulations to all the participants of City2Surf 2023 who successfully completed the challenging 14km course among a massive field of 80,000 competitors.
The 2023 Annual Scientific Meeting showcased the latest lung cancer research highlighting the importance of a multidisciplinary approach.
On May 2, 2023, the Australian Government announced a significant investment of $263.8 million over four years to establish the national Lung Cancer Screening Program
Recommendation by the Medical Services Advisory Committee (MSAC).
Teletrials, also known as digi trials, are when a clinician at a primary site uses telehealth (videoconference or telephone calls) to enrol, consent, treat and/or
